In my practice, notes Dr Talal Khan, CEO at Khan Longevity Care (pictured), many patients describe a reduction in what is often called “food noise” — those persistent or intrusive thoughts about food.
They may report fewer impulsive eating decisions, less urgency around cravings and a greater ability to control their choices.
Responses vary considerably from person to person, but these observations have raised an intriguing question: could GLP-1 medications also influence cravings beyond food?
Researchers are now studying whether medications such as semaglutide may affect alcohol use, nicotine cravings and potentially other reward-driven behaviours.
GLP-1 (glucagon-like peptide-1) is a naturally occurring hormone involved in blood sugar regulation, appetite and satiety.
GLP-1 receptor agonists mimic this signalling, thereby helping to reduce food intake and improve metabolic control.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Nutraceutical Business Review.
Subscribe now Already a subscriber? Sign in here.
